{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:59:11Z","timestamp":1764997151433},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T00:00:00Z","timestamp":1514505600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Basic Science Research Programs through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology","award":["NRF-2017R1A2B4006015"],"award-info":[{"award-number":["NRF-2017R1A2B4006015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s10067-017-3963-4","type":"journal-article","created":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T14:49:53Z","timestamp":1514558993000},"page":"1351-1358","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Assessment of cardiovascular risk profile based on measurement of tophus volume in patients with gout"],"prefix":"10.1007","volume":"37","author":[{"given":"Kyung-Ann","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se-Ri","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong-Jun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hae-Rim","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Heon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,29]]},"reference":[{"issue":"2","key":"3963_CR1","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s11926-013-0400-9","volume":"16","author":"MA Martillo","year":"2014","unstructured":"Martillo MA, Nazzal L, Crittenden DB (2014) The crystallization of monosodium urate. Curr Rheumatol Rep 16(2):400. \nhttps:\/\/doi.org\/10.1007\/s11926-013-0400-9","journal-title":"Curr Rheumatol Rep"},{"key":"3963_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ijcard.2016.11.268","volume":"231","author":"M Kuwabara","year":"2017","unstructured":"Kuwabara M, Niwa K, Nishihara S, Nishi Y, Takahashi O, Kario K, Yamamoto K, Yamashita T, Hisatome I (2017) Hyperuricemia is an independent competing risk factor for atrial fibrillation. Int J Cardiol 231:137\u2013142. \nhttps:\/\/doi.org\/10.1016\/j.ijcard.2016.11.268","journal-title":"Int J Cardiol"},{"issue":"4","key":"3963_CR3","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1253\/circj.CJ-08-0626","volume":"73","author":"H Mitsuhashi","year":"2009","unstructured":"Mitsuhashi H, Yatsuya H, Matsushita K, Zhang H, Otsuka R, Muramatsu T, Takefuji S, Hotta Y, Kondo T, Murohara T, Toyoshima H, Tamakoshi K (2009) Uric acid and left ventricular hypertrophy in Japanese men. Circ J 73(4):667\u2013672. \nhttps:\/\/doi.org\/10.1253\/circj.CJ-08-0626","journal-title":"Circ J"},{"issue":"8","key":"3963_CR4","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/eurheartj\/ehu403","volume":"36","author":"JC Mason","year":"2015","unstructured":"Mason JC, Libby P (2015) Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. European Heart J 36(8):482\u2013489. \nhttps:\/\/doi.org\/10.1093\/eurheartj\/ehu403","journal-title":"European Heart J"},{"issue":"1","key":"3963_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jbspin.2015.12.003","volume":"84","author":"HJ Janssens","year":"2017","unstructured":"Janssens HJ, Arts PG, Schalk BW, Biermans MC (2017) Gout and rheumatoid arthritis, both to keep in mind in cardiovascular risk management: a primary care retrospective cohort study. Joint, Bone, Spine: Revue du Rhumatisme 84(1):59\u201364. \nhttps:\/\/doi.org\/10.1016\/j.jbspin.2015.12.003","journal-title":"Joint, Bone, Spine: Revue du Rhumatisme"},{"issue":"2","key":"3963_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/ard.2009.113696","volume":"69","author":"MJ Peters","year":"2010","unstructured":"Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69(2):325\u2013331. \nhttps:\/\/doi.org\/10.1136\/ard.2009.113696","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"3963_CR7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1055\/s-0035-1569252","volume":"19","author":"P Omoumi","year":"2015","unstructured":"Omoumi P, Verdun FR, Guggenberger R, Andreisek G, Becce F (2015) Dual-energy CT: basic principles, technical approaches, and applications in musculoskeletal imaging (part 2). Semin Musculoskelet Radiol 19(5):438\u2013445. \nhttps:\/\/doi.org\/10.1055\/s-0035-1569252","journal-title":"Semin Musculoskelet Radiol"},{"issue":"10","key":"3963_CR8","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.3899\/jrheum.090370","volume":"36","author":"HR Schumacher","year":"2009","unstructured":"Schumacher HR, Taylor W, Edwards L, Grainger R, Schlesinger N, Dalbeth N et al (2009) Outcome domains for studies of acute and chronic gout. J Rheumatol 36(10):2342\u20132345. \nhttps:\/\/doi.org\/10.3899\/jrheum.090370","journal-title":"J Rheumatol"},{"issue":"9","key":"3963_CR9","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1007\/s10067-017-3729-z","volume":"36","author":"DV Modjinou","year":"2017","unstructured":"Modjinou DV, Krasnokutsky S, Gyftopoulos S, Pike VC, Karis E, Keenan RT, Lee K, Crittenden DB, Samuels J, Pillinger MH (2017) Comparison of dual-energy CT, ultrasound and surface measurement for assessing tophus dissolution during rapid urate debulking. Clin Rheumatol 36(9):2101\u20132107. \nhttps:\/\/doi.org\/10.1007\/s10067-017-3729-z","journal-title":"Clin Rheumatol"},{"key":"3963_CR10","doi-asserted-by":"crossref","first-page":"e000075","DOI":"10.1136\/rmdopen-2015-000075","volume":"1","author":"EG Araujo","year":"2015","unstructured":"Araujo EG, Bayat S, Petsch C, Englbrecht M, Faustini F, Kleyer A et al (2015) Tophus resolution with pegloticase: a prospective dual-energy CT study. RMD open 1:e000075","journal-title":"RMD open"},{"issue":"18","key":"3963_CR11","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","volume":"97","author":"PW Wilson","year":"1998","unstructured":"Wilson PW, D\u2019Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97(18):1837\u20131847. \nhttps:\/\/doi.org\/10.1161\/01.CIR.97.18.1837","journal-title":"Circulation"},{"issue":"6","key":"3963_CR12","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D\u2019Agostino Sr","year":"2008","unstructured":"D\u2019Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM et al (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117(6):743\u2013753. \nhttps:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.699579","journal-title":"Circulation"},{"issue":"17","key":"3963_CR13","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F, American Heart Association, National Heart, Lung, and Blood Institute (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112(17):2735\u20132752. \nhttps:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.169404","journal-title":"Circulation"},{"issue":"6","key":"3963_CR14","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3346\/jkms.2005.20.6.1029","volume":"20","author":"YH Rho","year":"2005","unstructured":"Rho YH, Choi SJ, Lee YH, Ji JD, Choi KM, Baik SH, Chung S, Kim CG, Choe JY, Lee SW, Chung WT, Song GG (2005) The prevalence of metabolic syndrome in patients with gout: a multicenter study. J Korean Med Sci 20(6):1029\u20131033. \nhttps:\/\/doi.org\/10.3346\/jkms.2005.20.6.1029","journal-title":"J Korean Med Sci"},{"key":"3963_CR15","doi-asserted-by":"crossref","unstructured":"Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D et al. 2015 gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis & rheumatology (Hoboken, NJ) 2015;67 10: 2557-68","DOI":"10.1002\/art.39254"},{"key":"3963_CR16","unstructured":"Panel TRotNCEPNE. Detection evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). National Cholesterol Education Program National Heart, Lung, and Blood Institute National Institutes of Health"},{"issue":"6","key":"3963_CR17","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s00330-009-1300-2","volume":"19","author":"C Thomas","year":"2009","unstructured":"Thomas C, Patschan O, Ketelsen D, Tsiflikas I, Reimann A, Brodoefel H, Buchgeister M, Nagele U, Stenzl A, Claussen C, Kopp A, Heuschmid M, Schlemmer HP (2009) Dual-energy CT for the characterization of urinary calculi: in vitro and in vivo evaluation of a low-dose scanning protocol. Eur Radiol 19(6):1553\u20131559. \nhttps:\/\/doi.org\/10.1007\/s00330-009-1300-2","journal-title":"Eur Radiol"},{"issue":"1","key":"3963_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12891-016-0943-9","volume":"17","author":"AN Baer","year":"2016","unstructured":"Baer AN, Kurano T, Thakur UJ, Thawait GK, Fuld MK, Maynard JW, McAdams-DeMarco M, Fishman EK, Carrino JA (2016) Dual-energy computed tomography has limited sensitivity for non-tophaceous gout: a comparison study with tophaceous gout. BMC Musculoskelet Disord 17(1):91. \nhttps:\/\/doi.org\/10.1186\/s12891-016-0943-9","journal-title":"BMC Musculoskelet Disord"},{"key":"3963_CR19","doi-asserted-by":"publisher","unstructured":"Full LE, Ruisanchez C, Monaco C (2009) The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther 11(2):217. \nhttps:\/\/doi.org\/10.1186\/ar2631","DOI":"10.1186\/ar2631"},{"issue":"12","key":"3963_CR20","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1002\/art.39318","volume":"67","author":"LB Kienhorst","year":"2015","unstructured":"Kienhorst LB, van Lochem E, Kievit W, Dalbeth N, Merriman ME, Phipps-Green A et al (2015) Gout is a chronic inflammatory disease in which high levels of interleukin-8 (CXCL8), myeloid-related protein 8\/myeloid-related protein 14 complex, and an altered proteome are associated with diabetes mellitus and cardiovascular disease. Arthritis Rheumatol 67(12):3303\u20133313. \nhttps:\/\/doi.org\/10.1002\/art.39318","journal-title":"Arthritis Rheumatol"},{"issue":"7081","key":"3963_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440(7081):237\u2013241. \nhttps:\/\/doi.org\/10.1038\/nature04516","journal-title":"Nature"},{"issue":"3","key":"3963_CR22","first-page":"234","volume":"17","author":"MH Snow","year":"2005","unstructured":"Snow MH, Mikuls TR (2005) Rheumatoid arthritis and cardiovascular disease: the role of systemic inflammation and evolving strategies of prevention. Curr Opin Rheumatol 17(3):234\u2013241","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"3963_CR23","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1080\/15257770802257952","volume":"27","author":"C Gersch","year":"2008","unstructured":"Gersch C, Palii SP, Kim KM, Angerhofer A, Johnson RJ, Henderson GN (2008) Inactivation of nitric oxide by uric acid. Nucleosides Nucleotides Nucleic Acids 27(8):967\u2013978. \nhttps:\/\/doi.org\/10.1080\/15257770802257952","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"2","key":"3963_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/15257770902736400","volume":"28","author":"C Gersch","year":"2009","unstructured":"Gersch C, Palii SP, Imaram W, Kim KM, Karumanchi SA, Angerhofer A, Johnson RJ, Henderson GN (2009) Reactions of peroxynitrite with uric acid: formation of reactive intermediates, alkylated products and triuret, and in vivo production of triuret under conditions of oxidative stress. Nucleosides Nucleotides Nucleic Acids 28(2):118\u2013149. \nhttps:\/\/doi.org\/10.1080\/15257770902736400","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"5","key":"3963_CR25","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","volume":"67","author":"UM Khosla","year":"2005","unstructured":"Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67(5):1739\u20131742. \nhttps:\/\/doi.org\/10.1111\/j.1523-1755.2005.00273.x","journal-title":"Kidney Int"},{"issue":"8","key":"3963_CR26","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1136\/annrheumdis-2012-201916","volume":"72","author":"AL Gaffo","year":"2013","unstructured":"Gaffo AL, Jacobs DR Jr, Sijtsma F, Lewis CE, Mikuls TR, Saag KG (2013) Serum urate association with hypertension in young adults: analysis from the Coronary Artery Risk Development in Young Adults cohort. Ann Rheum Dis 72(8):1321\u20131327. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2012-201916","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3963_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.rdc.2014.01.005","volume":"40","author":"SE Sattui","year":"2014","unstructured":"Sattui SE, Singh JA, Gaffo AL (2014) Comorbidities in patients with crystal diseases and hyperuricemia. Rheum Dis Clin N Am 40(2):251\u2013278. \nhttps:\/\/doi.org\/10.1016\/j.rdc.2014.01.005","journal-title":"Rheum Dis Clin N Am"},{"issue":"3","key":"3963_CR28","doi-asserted-by":"publisher","first-page":"176\u201384","DOI":"10.1016\/j.dsx.2010.07.010","volume":"4","author":"B Mankovsky","year":"2010","unstructured":"Mankovsky B, Kurashvili R, Sadikot S (2010) Is serum uric acid a risk factor for atherosclerotic cardiovascular disease?: a review of the clinical evidence. Part 1. Diabetes Metabolic Syndrome: Clinical Res Rev 4(3):176\u201384\u2013176184. \nhttps:\/\/doi.org\/10.1016\/j.dsx.2010.07.010","journal-title":"Diabetes Metabolic Syndrome: Clinical Res Rev"},{"issue":"6","key":"3963_CR29","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1751-7176.2012.00662.x","volume":"14","author":"DI Feig","year":"2012","unstructured":"Feig DI (2012) The role of uric acid in the pathogenesis of hypertension in the young. Journal Clinical Hypertension 14(6):346\u2013352. \nhttps:\/\/doi.org\/10.1111\/j.1751-7176.2012.00662.x","journal-title":"Journal Clinical Hypertension"},{"issue":"1","key":"3963_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13075-017-1381-2","volume":"19","author":"T Pascart","year":"2017","unstructured":"Pascart T, Grandjean A, Norberciak L, Ducoulombier V, Motte M, Luraschi H, Vandecandelaere M, Godart C, Houvenagel E, Namane N, Budzik JF (2017) Ultrasonography and dual-energy computed tomography provide different quantification of urate burden in gout: results from a cross-sectional study. Arthritis Res Ther 19(1):171. \nhttps:\/\/doi.org\/10.1186\/s13075-017-1381-2","journal-title":"Arthritis Res Ther"},{"issue":"20","key":"3963_CR31","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1161\/CIRCULATIONAHA.105.539528","volume":"112","author":"PW Wilson","year":"2005","unstructured":"Wilson PW, D\u2019Agostino RB, Parise H, Sullivan L, Meigs JB (2005) Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112(20):3066\u20133072. \nhttps:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.539528","journal-title":"Circulation"},{"issue":"4\u20136","key":"3963_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/15257770.2013.853785","volume":"33","author":"NM Gonzalez-Senac","year":"2014","unstructured":"Gonzalez-Senac NM, Bailen R, Torres RJ, de Miguel E, Puig JG (2014) Metabolic syndrome in primary gout. Nucleosides Nucleotides Nucleic Acids 33(4\u20136):185\u2013191. \nhttps:\/\/doi.org\/10.1080\/15257770.2013.853785","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"12","key":"3963_CR33","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1093\/rheumatology\/keq256","volume":"49","author":"Y Zhu","year":"2010","unstructured":"Zhu Y, Zhang Y, Choi HK (2010) The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the Multiple Risk Factor Intervention Trial. Rheumatology 49(12):2391\u20132399. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/keq256","journal-title":"Rheumatology"},{"issue":"7","key":"3963_CR34","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1001\/archinte.165.7.742","volume":"165","author":"HK Choi","year":"2005","unstructured":"Choi HK, Atkinson K, Karlson EW, Curhan G (2005) Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 165(7):742\u2013748. \nhttps:\/\/doi.org\/10.1001\/archinte.165.7.742","journal-title":"Arch Intern Med"},{"key":"3963_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2015.11.026","volume":"29","author":"M Kanbay","year":"2016","unstructured":"Kanbay M, Jensen T, Solak Y, Le M, Roncal-Jimenez C, Rivard C, Lanaspa MA, Nakagawa T, Johnson RJ (2016) Uric acid in metabolic syndrome: from an innocent bystander to a central player. European J Internal Medicine 29:3\u20138. \nhttps:\/\/doi.org\/10.1016\/j.ejim.2015.11.026","journal-title":"European J Internal Medicine"},{"issue":"17","key":"3963_CR36","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra0800885","volume":"359","author":"DI Feig","year":"2008","unstructured":"Feig DI, Kang D-H, Johnson RJ (2008) Uric acid and cardiovascular risk. N Engl J Med 359(17):1811\u20131821. \nhttps:\/\/doi.org\/10.1056\/NEJMra0800885","journal-title":"N Engl J Med"},{"issue":"6","key":"3963_CR37","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","volume":"41","author":"RJ Johnson","year":"2003","unstructured":"Johnson RJ, Kang D-H, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41(6):1183\u20131190. \nhttps:\/\/doi.org\/10.1161\/01.HYP.0000069700.62727.C5","journal-title":"Hypertension"},{"issue":"8","key":"3963_CR38","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2215\/CJN.01580210","volume":"5","author":"M Goicoechea","year":"2010","unstructured":"Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rinc\u00f3n A et al (2010) Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 5(8):1388\u20131393. \nhttps:\/\/doi.org\/10.2215\/CJN.01580210","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"3963_CR39","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3109\/09513590.2015.1056730","volume":"31","author":"S Yu","year":"2015","unstructured":"Yu S, Yang H, Guo X, Zheng L, Sun Y (2015) Hyperuricemia is independently associated with left ventricular hypertrophy in post-menopausal women but not in pre-menopausal women in rural Northeast China. Gynecol Endocrinol 31(9):736\u2013741. \nhttps:\/\/doi.org\/10.3109\/09513590.2015.1056730","journal-title":"Gynecol Endocrinol"},{"key":"3963_CR40","doi-asserted-by":"publisher","unstructured":"Lin JC, Lin CL, Chen MC, Chang PJ, Chang ST, Chung CM, et al (2015) Gout, not hyperuricemia alone, impairs left ventricular diastolic function. Arthritis Res Ther 17:323. \nhttps:\/\/doi.org\/10.1186\/s13075-015-0842-8","DOI":"10.1186\/s13075-015-0842-8"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3963-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3963-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3963-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T10:07:11Z","timestamp":1524478031000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3963-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,29]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["3963"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3963-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,29]]}}}